Bill > SR77

This Resolution formally recognizes and supports the ongoing collaborative efforts by various state agencies and private organizations in Hawaii to implement "Hep Free 2030," a ten-year strategy aimed at eliminating viral hepatitis types A, B, and C by the year 2030. Viral hepatitis, an inflammation of the liver caused by a virus, is a significant public health concern in Hawaii, with hepatitis B and C linked to serious conditions like cirrhosis and liver cancer, affecting residents at disproportionately high rates. The Resolution acknowledges that certain communities, including indigenous, Asian American and Pacific Islander, incarcerated, veteran, homeless, pregnant, and LGBTQ+ individuals, are at higher risk. It highlights existing state initiatives such as expanding health coverage for hepatitis C medications, offering syringe service programs, and ensuring vaccinations for at-risk groups. Furthermore, the Resolution requests that the Senate and House of Representatives' health committees hold a joint informational briefing to review the progress of the Hep Free 2030 strategy and consider any necessary future legislative actions.